BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12700456)

  • 21. High mortality rates in tuberculosis patients in Zomba Hospital, Malawi, during 32 months of follow-up.
    Kang'ombe C; Harries AD; Banda H; Nyangulu DS; Whitty CJ; Salaniponi FM; Maher D; Nunn P
    Trans R Soc Trop Med Hyg; 2000; 94(3):305-9. PubMed ID: 10975007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
    Agbor AA; Bigna JJ; Billong SC; Tejiokem MC; Ekali GL; Plottel CS; Noubiap JJ; Abessolo H; Toby R; Koulla-Shiro S
    PLoS One; 2014; 9(12):e115211. PubMed ID: 25506830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of collaboration in the TB and HIV control programme in Oromia Region, Ethiopia: Seven years of retrospective data.
    Sisay S; Mekonen A; Abera A; Berhan Y; Kebede T; Ferede A
    Int J Infect Dis; 2018 Dec; 77():74-81. PubMed ID: 30336266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV.
    Grimwade K; Swingler ; G
    Cochrane Database Syst Rev; 2003; 2003(3):CD003108. PubMed ID: 12917946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
    Muyaya LM; Musanda EM; Tamuzi JL
    BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Escherichia coli resistance to co-trimoxazole in tuberculosis patients and in relation to co-trimoxazole prophylaxis in Thyolo, Malawi.
    Zachariah R; Harries AD; Spielmann MP; Arendt V; Nchingula D; Mwenda R; Courtielle O; Kirpach P; Mwale B; Salaniponi FM
    Trans R Soc Trop Med Hyg; 2002; 96(2):202-4. PubMed ID: 12055816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
    Lawn SD; Harries AD; Meintjes G; Getahun H; Havlir DV; Wood R
    AIDS; 2012 Nov; 26(17):2121-33. PubMed ID: 22695302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV/AIDS clinic in Uganda.
    Watera C; Todd J; Muwonge R; Whitworth J; Nakiyingi-Miiro J; Brink A; Miiro G; Antvelink L; Kamali A; French N; Mermin J
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):373-8. PubMed ID: 16810124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi.
    Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM
    Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The scourge of HIV-related tuberculosis: a cohort study in a district general hospital in Malawi.
    Harries AD; Nyangulu DS; Kangombe C; Ndalama D; Wirima JJ; Salaniponi FM; Liomba G; Maher D; Nunn P
    Ann Trop Med Parasitol; 1997 Oct; 91(7):771-6. PubMed ID: 9625933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality among tuberculosis patients under DOTS programme: a historical cohort study.
    Beyene Y; Geresu B; Mulu A
    BMC Public Health; 2016 Aug; 16(1):883. PubMed ID: 27561794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial.
    Wiktor SZ; Sassan-Morokro M; Grant AD; Abouya L; Karon JM; Maurice C; Djomand G; Ackah A; Domoua K; Kadio A; Yapi A; Combe P; Tossou O; Roels TH; Lackritz EM; Coulibaly D; De Cock KM; Coulibaly IM; Greenberg AE
    Lancet; 1999 May; 353(9163):1469-75. PubMed ID: 10232312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.
    Pitter C; Kahn JG; Marseille E; Lule JR; McFarland DA; Ekwaru JP; Bunnell R; Coutinho A; Mermin J
    J Acquir Immune Defic Syndr; 2007 Mar; 44(3):336-43. PubMed ID: 17327758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi.
    Zachariah R; Teck R; Buhendwa L; Labana S; Chinji C; Humblet P; Harries AD
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):167-75. PubMed ID: 16214192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
    Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-associated TB in An Giang Province, Vietnam, 2001-2004: epidemiology and TB treatment outcomes.
    Thuy TT; Shah NS; Anh MH; Nghia do T; Thom D; Linh T; Sy DN; Duong BD; Chau LT; Mai PT; Wells CD; Laserson KF; Varma JK
    PLoS One; 2007 Jun; 2(6):e507. PubMed ID: 17551587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How human immunodeficiency virus voluntary testing can contribute to tuberculosis control.
    Godfrey-Faussett P; Maher D; Mukadi YD; Nunn P; Perriëns J; Raviglione M
    Bull World Health Organ; 2002; 80(12):939-45. PubMed ID: 12571721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. District-randomized phased implementation: strengthening the evidence base for cotrimoxazole for HIV-positive tuberculosis patients.
    Godfrey-Faussett P
    AIDS; 2003 May; 17(7):1079-81. PubMed ID: 12700460
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya.
    Huerga H; Spillane H; Guerrero W; Odongo A; Varaine F
    Int J Tuberc Lung Dis; 2010 May; 14(5):611-5. PubMed ID: 20392355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.